A premier collection of drug-focused publications across the medical, biomedical and pharmacological areas.
Adis is a reputable publisher providing unique and valued content to its readers. The Adis journals portfolio hosts a set of unique titles with highlights setting them apart from their competitors. The journals are all peer reviewed; many with expert in-house Editors-in-Chief overseeing the quality of the articles being published.
A leading provider of drug information offering authoritative reviews of complex clinical and specialist data as well as cutting-edge original research in all therapy areas. An invaluable source of information for anyone involved in medical research, practice or teaching, drug regulation or reimbursement, or any part of the pharmaceutical industry.
The Adis Drug Review program provides readers with the most important and clinically relevant information on the properties of new and established drugs in all therapeutic areas. Adis Drug Reviews are written by a specialist in-house team and rigorously peer reviewed by international experts. A trusted resource for healthcare practitioners for more than 50 years.
Adis offers a specialist newsletter, to keep you informed on the latest developments in the field of Drug Safety. Reactions Weekly offers summaries of the world's adverse drug reaction news and adverse drug reaction case reports.
